Patents by Inventor Pablo Oppezzo

Pablo Oppezzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IONIC CHANNEL MODULATION AS A METHOD FOR TREATING TUMORS THROUGH INFLAMMASOME ACTIVATION
    Publication number: 20220184004
    Abstract: The invention presents use of ion channel modulator to manipulate expression of the Tmem176b gene, also known as TORID (TOlerance Related and InduceD), to treat tumors.
    Type: Application
    Filed: October 28, 2021
    Publication date: June 16, 2022
    Inventors: Marcelo HILL MONGABURE, Sofia RUSSO ROSSI, Mercedes SEGOVIA DUARTE, María INÉS VARELA VEGA, Pablo OPPEZZO LLORENS
  • Antibody specific for the Tn antigen for the treatment of cancer
    Publication number: 20100278818
    Abstract: The instant application provides a pharmaceutical composition comprising an antibody, directed against Tn antigen which comprises CDRs derived from 83D4 monoclonal antibody or an immunoconjugate of said antibody, said pharmaceutical composition being intended for the treatment of cancer.
    Type: Application
    Filed: June 19, 2008
    Publication date: November 4, 2010
    Applicant: INSTITUT CURIE
    Inventors: Pascale Hubert-Haddad, Sebastian Amigorena, Xavier Sastre, Eduardo Osinaga, Otto Pritsch, Pablo Oppezzo, Franck Perez, Sandrine Moutel
  • METHOD OF DIAGNOSIS/PROGNOSIS OF HUMAN CHRONIC LYMPHOCYTIC LEUKEMIA COMPRISING THE PROFILING OF LPL/ADAM GENES
    Publication number: 20090081665
    Abstract: The present invention provides methods of diagnosis and prognosis of human chronic lymphocytic leukemia (CLL) in a subject a patient in need thereof. The methods of the present invention involve measuring the expression profile of two known genes: LPL and ADAM29; and comparing the ratio of their expression to diagnose the presence of CLL or to prognose the likelihood of developing CLL or the symptoms consistent with CLL.
    Type: Application
    Filed: April 24, 2008
    Publication date: March 26, 2009
    Applicant: INSTITUT PASTEUR
    Inventors: Frederic Davi, Guillaume Dighiero, Gerard Dumas, Pablo Oppezzo, Catherine Settegrana, Yuri Vasconcelos Pinheiro
  • Method of diagnosis/prognosis of human chronic lymphocytic leukemia comprising the profiling of genes
    Patent number: 7416851
    Abstract: The present invention provides methods of diagnosis and prognosis of human chronic lymphocytic leukemia (CLL) in a subject a patient in need thereof. The methods of the present invention involve measuring the expression profile of two known genes: LPL and ADAM29; and comparing the ratio of their expression to diagnose the presence of CLL or to prognose the likelihood of developing CLL or the symptoms consistent with CLL.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: August 26, 2008
    Assignee: Institut Pasteur
    Inventors: Frederic Davi, Guillaume Dighiero, Gerard Dumas, Pablo Oppezzo, Catherine Settegrana, Yuri Vasconcelos Pinheiro